OKYO Pharma Ltd (OKYO) stock
OKYONasdaqBiological Products, (No Diagnostic Substances)
$1.16+0.06 (+5.45%)
Close on Nov 19, 2026Market cap $60.88MP/E –Yield –
OKYO Pharma free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2026 it was -$5.94M. The highest annual figure on record is -$1.61M in fiscal 2021.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$5.94M | – |
| FY2025 | Mar 31, 2025 | -$1.81M | – |
| FY2023 | Mar 31, 2023 | -$7.70M | – |
| FY2022 | Mar 31, 2022 | -$5.47M | – |
| FY2021 | Mar 31, 2021 | -$1.61M | – |
See a number that looks wrong?